Vaccine Maker Novavax Soars 150%


As we guessed, shares of small cap vaccine maker Novavax (NVAX) are going crazy this morning, soaring about 150% on the swinf flu news. That follows a 70% gain on Friday, so between the two days, you’re looking at a gain of over 400% since last Thursday.

Not bad.

Another one, Biocryst (BCRX) is up 90%, as it collects royalties from the sale of Tamiflu.

Now the question is: Can any of these companies actually turn a panic into a real business? For now, these companies are mainly going to appeal to traders.

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at